Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
private placement
Fierce Pharma
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
The debt refinancing and private placement represent Sarepta's latest move in a series of intensive measures to improve its financial position.
Angus Liu
Aug 21, 2025 10:52am
Oruka spins out of Paragon with assets, public listing and cash
Apr 3, 2024 7:30am
Avrobio's corporate tremor attracts Tectonic for reverse merger
Jan 30, 2024 3:24pm
BridgeBio bags $250M in stock sale before acoramidis submission
Sep 25, 2023 11:20am
SpringWorks enjoys double payday from GSK deal, $225M funding
Sep 7, 2022 10:49am
Provention snags $60M to prep for diabetes drug launch
Jul 8, 2022 10:52am
